Recognized for its knowledge in the life sciences, WilmerHale has represented life sciences clients across the United States and internationally for more than four decades. We understand the business of our life sciences clients and the unique regulatory and competitive demands they face. Our clients include biotechnology, pharmaceutical, diagnostic and medical device companies at all stages of growth and other key players in the space, including venture capitalists, investment banks, universities and research institutions.
WilmerHale’s Life Sciences Practice has extraordinary breadth and depth, with a multidisciplinary team with experience and skills to address a broad range of matters for clients, including corporate finance, corporate governance and disclosure, licensing and strategic alliances, mergers and acquisitions, executive compensation and tax, patent litigation and licensing disputes, patent drafting and prosecution, strategic IP counseling, Food and Drug Administration (FDA) matters, competition and other regulatory matters, government investigations and litigation, real estate transactions and securities litigation and enforcement.
To learn more about WilmerHale's Life Sciences practice, visit: https://www.wilmerhale.com/en/solutions/life-sciences
